HUMTICKER
Humana Inc.
Congress has disclosed 39 buys and 21 sells of HUM (Humana Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
39
Buy
21
Sell
+18
Net
13
Active politicians
Round-trip watch Still on the books
Members who disclosed buying HUM and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 | $168.33 | $414.50 | +146.2% | in profit |
| Rohit Khanna | 2025-05-19 | $242.41 | $414.50 | +71.0% | in profit |
| Michael McCaul | 2026-05-07 | $246.02 | $414.50 | +68.5% | in profit |
| Lisa McClain | 2025-10-30 | $281.93 | $414.50 | +47.0% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Insurance. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
44.04
▲ pricier than
Insurance (median 13.5)
how it's calculated
P/E = price ÷ earnings per share
$414.50 ÷ $9.41 = 44.04
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
2.68
▲ pricier than
Insurance (median 2.0)
how it's calculated
P/B = price ÷ book value per share
$414.50 ÷ $154.75 = 2.68
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
18.72
▲ pricier than
Insurance (median 13.6)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($49.8B + $9.0B net debt) ÷ $3.1B = $58.8B ÷ $3.1B = 18.72
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Insurance). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10820 | Epstein Wall Street Records Act of 2026 | Finance and Financial Sector | 2026-10-15 |
| HR 10821 | To amend the Federal Deposit Insurance Act to make changes to the Standard Maximum Deposit Insurance Amount, and for other purposes. | Finance and Financial Sector | 2026-10-15 |
| S 4395 | Terrorism Risk Insurance Program Reauthorization Act of 2026 | Finance and Financial Sector | 2026-10-05 |
| S 1564 | Floodplain Enhancement and Recovery Act | Finance and Financial Sector | 2026-10-05 |
| S 5644 | A bill to amend title 31, United States Code, to exempt transactions with respect to cash reward payments by crime stopper organizations from certain currency transaction reports. | Finance and Financial Sector | 2026-09-30 |
60 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Michael McCaul | House | BUY OCR | Spouse | 2026-05-07 | 29 days | +41.7% | $1K–$15K | 9.5 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2026-05-04 | 32 days | +47.1% | $1K–$15K | 9.5 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider convergence · moderate | Spouse | 2026-04-10 | 22 days | +21.6% | $1K–$15K | 17.8 | ↗ filing |
| Alan Armstrong | Senate | BUY ◆ insider convergence · moderate | Self | 2026-03-27 | 116 days | +139.7% | $1K–$15K | 89.2 | ↗ eFD |
| Michael McCaul | House | SELL OCR ◆ insider divergence · moderate | Spouse | 2026-02-17 | 16 days | -2.3% | $50K–$100K | 49.1 | ↗ filing |
| Julia Letlow | House | SELL ◆ insider divergence · moderate | Self · Merrill Lynch Investment Account #025 | 2026-02-10 | 19 days | +5.1% | $1K–$15K 1.0% of NW |
50.7 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self · 150 Main Street Trust > Bank of America | 2025-11-12 | 30 days | +11.6% | $1K–$15K 0.1% of NW |
18.8 | ↗ filing |
| Michael McCaul | House | SELL OCR | Spouse | 2025-11-04 | 31 days | -8.5% | $15K–$50K | 48.7 | ↗ filing |
| Lisa McClain | House | SELL | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-31 | 1 days | 0.0% | $1K–$15K 0.1% of NW |
82.6 | ↗ filing |
| Lisa McClain | House | SELL | Spouse · Charles Schwab Brokerage Account 924 | 2025-10-30 | 2 days | -2.6% | $1K–$15K 0.1% of NW |
88.6 | ↗ filing |
| Lisa McClain | House | BUY | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-30 | 2 days | -2.6% | $1K–$15K 0.1% of NW |
67.3 | ↗ filing |
| Michael McCaul | House | SELL OCR | Spouse | 2025-10-27 | 9 days | -9.4% | $15K–$50K | 48.7 | ↗ filing |
| Lisa McClain | House | BUY | Spouse · Charles Schwab Brokerage Account 924 | 2025-09-25 | 6 days | -2.7% | $1K–$15K 0.1% of NW |
84.8 | ↗ filing |
| Julia Letlow | House | BUY | Self · Merrill Lynch Investment Account #025 | 2025-08-08 | 24 days | +13.9% | $1K–$15K 1.0% of NW |
69.8 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self · 150 Main Street Trust > Bank of America | 2025-08-05 | 34 days | +22.0% | $1K–$15K 0.1% of NW |
11.7 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider convergence · strong | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-24 | 50 days | +18.5% | $1K–$15K 0.1% of NW |
98.1 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider divergence · strong | Self · 150 Main Street Trust > Bank of America | 2025-05-30 | 5 days | -1.0% | $1K–$15K 0.1% of NW |
17.3 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider convergence · strong | Spouse | 2025-05-28 | 8 days | -0.3% | $15K–$50K | 48.5 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · strong | Child | 2025-05-19 | 21 days | -5.8% | $1K–$15K | 12.3 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider convergence · strong | Spouse | 2025-05-19 | 17 days | -8.2% | $50K–$100K | 47.6 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider convergence · strong | Spouse | 2025-05-19 | 17 days | -8.2% | $15K–$50K | 29.7 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider divergence · strong | Self · JP Morgan Brokerage Account | 2025-05-15 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
33.6 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider divergence · strong | Self · 150 Main Street Trust > Bank of America | 2025-04-29 | 6 days | -1.0% | $1K–$15K 0.1% of NW |
20.3 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider convergence · strong | Spouse | 2025-04-10 | 25 days | -11.6% | $100K–$250K | 49.1 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence | Self · 150 Main Street Trust > Bank of America | 2025-02-26 | 6 days | +3.0% | $1K–$15K 0.1% of NW |
50.8 | ↗ filing |
| Rob Bresnahan | House | BUY ◆ insider divergence | Self · JP Morgan Brokerage Account | 2025-02-25 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
82.6 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2025-02-25 | 8 days | +1.1% | $1K–$15K | 24.8 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence | Spouse | 2025-01-23 | 13 days | -1.1% | $100K–$250K | 49.1 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence | Spouse | 2025-01-15 | 21 days | +4.0% | $15K–$50K | 18.5 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence | Spouse | 2025-01-09 | 27 days | +8.4% | $50K–$100K | 29.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-11-15 | 19 days | +4.5% | $1K–$15K | 2.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR | Child | 2024-10-02 | 36 days | +16.5% | $1K–$15K | 13.4 | ↗ filing |
| John James | House | SELL | Self · John A. James Children’s Trust | 2024-09-04 | 1 days | -1.7% | $1K–$15K <0.1% of NW |
50.7 | ↗ filing |
| Michael McCaul | House | SELL OCR | Spouse | 2024-08-26 | 10 days | +3.4% | $50K–$100K | 47.6 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-05-22 | 14 days | — | $50K–$100K | 47.6 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-05-14 | 22 days | — | $50K–$100K | 48.5 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-05-02 | 34 days | — | $15K–$50K | 30.2 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-04-29 | 7 days | — | $15K–$50K | 33.1 | ↗ filing |
| Michael McCaul | House | BUY OCR | Child | 2024-04-29 | 7 days | — | $15K–$50K | 33.1 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2024-04-26 | 5 days | — | $1K–$15K | 14.1 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-04-24 | 12 days | — | $15K–$50K | 49.8 | ↗ filing |
| Michael McCaul | House | BUY OCR | Child | 2024-04-24 | 12 days | — | $15K–$50K | 49.8 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider convergence · moderate | Spouse | 2024-04-19 | 17 days | — | $15K–$50K | 63.1 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider convergence · moderate | Child | 2024-04-19 | 17 days | — | $15K–$50K | 63.1 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider convergence · moderate | Spouse | 2024-04-10 | 26 days | — | $15K–$50K | 94.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · moderate | Child | 2024-03-25 | 9 days | — | $1K–$15K | 17.4 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider divergence · moderate | Child | 2024-02-13 | 21 days | — | $1K–$15K | 8.6 | ↗ filing |
| John James | House | BUY | Self · John A. James Children’s Trust | 2023-11-10 | 277 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2023-09-13 | 22 days | — | $1K–$15K | 10.6 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-05-10 | 23 days | — | $1K–$15K | 15.7 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence · moderate | Child | 2023-04-12 | 21 days | — | $1K–$15K | 22.3 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence · moderate | Child | 2023-01-30 | 3 days | — | $1K–$15K | 40.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2023-01-11 | 22 days | — | $1K–$15K | 75.9 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-01-28 | 6 days | — | $1K–$15K | 75.9 | ↗ filing |
| John Yarmuth | House | BUY | Self | 2020-10-29 | 11 days | — | $1K–$15K | 75.9 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self | 2019-08-14 | 27 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Gary Palmer | House | BUY | Self | 2018-08-06 | 0 days | — | $1K–$15K 0.3% of NW |
40.4 | ↗ filing |
| Gary Palmer | House | SELL | Self | 2018-07-31 | 0 days | — | $1K–$15K 0.3% of NW |
75.9 | ↗ filing |
| Virginia Foxx | House | BUY | Joint | 2018-03-19 | 0 days | — | $15K–$50K 0.7% of NW |
90.9 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2018-02-14 | 223 days | — | $1K–$15K <0.1% of NW |
98.8 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in HUM — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
15
Congress trades with insider convergence
14
…with insider divergence
9
Insider open-market trades
Of the congressional trades in HUM, 15 coincided with corporate insiders moving the same way within 60 days, and 14 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-02-23 | Shetty Sanjay K | C-suite | BUY | $150K | ↗ EDGAR |
| 2025-05-14 | Rechtin James A. | C-suite | BUY | $1.5M | ↗ EDGAR |
| 2024-12-31 | Huval Timothy S. | C-suite | SELL | $949K | ↗ EDGAR |
| 2024-02-20 | Mesquita Jorge S. | Director | BUY | $200K | ↗ EDGAR |
| 2023-05-04 | Diamond Susan M | C-suite | SELL | $1.4M | ↗ EDGAR |
| 2023-05-04 | Diamond Susan M | C-suite | SELL | $790K | ↗ EDGAR |
| 2023-02-27 | Huval Timothy S. | C-suite | SELL | $1.3M | ↗ EDGAR |
| 2023-02-27 | Ventura Joseph C | C-suite | SELL | $1.0M | ↗ EDGAR |
| 2023-02-27 | BROUSSARD BRUCE D | C-suite | SELL | $8.9M | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| Congress | 2026-05-07 | Michael McCaul | BUY | $1K–$15K |
| Congress | 2026-05-04 | Michael McCaul | BUY | $1K–$15K |
| Congress | 2026-04-10 | Michael McCaul | BUY | $1K–$15K |
| Congress | 2026-03-27 | Alan Armstrong | BUY | $1K–$15K |
| ◆ insider | 2026-02-23 | Shetty Sanjay K C-suite | BUY | $150K |
| Congress | 2026-02-17 | Michael McCaul | SELL | $50K–$100K |
| Congress | 2026-02-10 | Julia Letlow | SELL | $1K–$15K |
| Congress | 2025-11-12 | Gilbert Cisneros | SELL | $1K–$15K |
| Congress | 2025-11-04 | Michael McCaul | SELL | $15K–$50K |
| Congress | 2025-10-31 | Lisa McClain | SELL | $1K–$15K |
| Congress | 2025-10-30 | Lisa McClain | SELL | $1K–$15K |
| Congress | 2025-10-30 | Lisa McClain | BUY | $1K–$15K |
| Congress | 2025-10-27 | Michael McCaul | SELL | $15K–$50K |
| Congress | 2025-09-25 | Lisa McClain | BUY | $1K–$15K |
| Congress | 2025-08-08 | Julia Letlow | BUY | $1K–$15K |
| Congress | 2025-08-05 | Gilbert Cisneros | BUY | $1K–$15K |
| Congress | 2025-06-24 | Lisa McClain | BUY | $1K–$15K |
| Congress | 2025-05-30 | Gilbert Cisneros | SELL | $1K–$15K |
| Congress | 2025-05-28 | Michael McCaul | BUY | $15K–$50K |
| Congress | 2025-05-19 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2025-05-19 | Michael McCaul | BUY | $50K–$100K |
| Congress | 2025-05-19 | Michael McCaul | BUY | $15K–$50K |
| Congress | 2025-05-15 | Rob Bresnahan | SELL | $1K–$15K |
| ◆ insider | 2025-05-14 | Rechtin James A. C-suite | BUY | $1.5M |
FAQ Common questions
How much has Congress traded HUM?
39 disclosed buys and 21 sells of HUM (Humana Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade HUM?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.